Cell-permeable probes for identification and imaging of sialidases

US10214765B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10214765-B2
Application numberUS-201815881581-A
CountryUS
Kind codeB2
Filing dateJan 26, 2018
Priority dateAug 18, 2012
Publication dateFeb 26, 2019
Grant dateFeb 26, 2019

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Provided herein are compounds for use as sialidase inhibitors, including alkynyl-3-fluorosialyl fluoride. The compounds, which include the compound DFSA, function by trapping a 3-fluorosialylenzyme intermediate (reporter-inhibitor-enzyme conjugate). These compounds can be conjugated with a detectable tagging moiety for isolation and identification of sialidases.

First claim

Opening claim text (preview).

We claim: 1. A compound of formula (I): or a salt thereof, wherein F atom at the C3-position is axial or equatorial; R 1 is H or C 1-6 alkyl; R 2 is OR 2O , N 3 , N(R 2N ) 2 , or —NH(C═NH)NH 2 ; each instance of R 2O is independently hydrogen, C 1-6 alkyl, acyl, or a hydroxyl protecting group; each instance of R 2N is independently hydrogen, C 1-6 alkyl, acyl, or an amine protecting group; each instance of R 3a and R 3b is independently hydrogen, —C(═O)—R 3r , or a hydroxyl protecting group; each instance of R 3r is C 1-6 alkyl, aryl, heteroaryl, heterocyclyl, alkylaryl, alkylheteroaryl, or alkylheterocyclyl; X is selected from the group consisting of —O—, —O(C═O)—, —NH—, —NH(C═O)—, —(C═O)NH—, —O(C═O)NH—, —O(C═S)NH—, —NH(C═O)NH—, and —NH(C═S)NH—; R 4 is H, C 1-6 alkyl, or -L-Z; Y is CF 3 , C 1-6 alkyl or -L-Z; each instance of L is independently selected from the group consisting of —(CH 2 ) n —, —(CH 2 ) n C═O—, —(CH 2 ) n NH—, —(C═O)(CH 2 ) n —, —(CH 2 ) n NH(C═O)—, —(C═O)(CH 2 ) n NH(C═O)—, —(CH 2 ) n SCH 2 (C═O)—, and —(CH 2 CH 2 O) n —; each instance of n is an integer from 1 to 8, inclusive; each instance of Z is alkynyl, alkenyl, halogen, N(R N ) 2 , OR O , SR S , or CO 2 R O ; each instance of R N is independently hydrogen, C 1-6 alkyl, acyl, or an amine protecting group; each instance of R O is independently hydrogen, C 1-6 alkyl, acyl, or a hydroxyl protecting group; each instance of R S is independently hydrogen, C 1-6 alkyl, or a thiol protecting group; provided that the compound is not of the formula provided that when R 4 is -L-Z, Y is C 1-6 alkyl; and provided that when Y is -L-Z, R 4 is H or C 1-6 alkyl. 2. The compound of claim 1 of formula (II-a): or a salt thereof, wherein R 3c is independently hydrogen, C 1-6 alkyl, acyl, or a hydroxyl protecting group. 3. The compound of claim 2 of formula (II-b): or a salt thereof. 4. The compound of claim 3 , having a formula (II-b1): or a salt thereof. 5. The compound of claim 4 , having the formula (II-b2): wherein R y1 is hydrogen, halogen, or C 1-6 alkyl, or a salt thereof. 6. The compound of claim 1 of formula (II-c): or a salt thereof. 7. The compound of claim 6 , having a formula selected from (II-c1) and (II-C2): wherein R y2 is hydrogen or C 1-6 alkyl, or a salt thereof. 8. The compound of claim 6 , wherein Y is C 1-6 alkyl. 9. The compound of claim 8 , wherein Y is methyl or CF 3 . 10. The compound of claim 1 , wherein R 1 is H or methyl. 11. The compound of claim 1 , wherein the F atom at the C3-position is axial. 12. The compound of claim 1 , wherein the F atom at the C3-position is equatorial. 13. The compound of claim 1 , wherein R 3a is —C(═O)—R 3r , wherein R 3r is C 1-6 alkyl or aryl. 14. The compound of claim 1 , wherein R 3a is benzoyl. 15. The compound of claim 1 , wherein R 3a is CH 3 CO—, C 2 H 5 CO—, C 3 H 7 CO—, t-BuCO—, CF 3 CO—, PhCH 2 CO—, or C 6 H 5 CO—. 16. The compound of claim 1 , wherein the compound is one of the following formulae:

Assignees

Inventors

Classifications

  • C12Q1/34Primary

    involving hydrolase · CPC title

  • Orthomyxoviridae, e.g. influenza virus · CPC title

  • Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor {(C12Q1/6897 takes precedence)} · CPC title

  • Exo-alpha-sialidase (3.2.1.18), i.e. trans-sialidase · CPC title

  • Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10214765B2 cover?
Provided herein are compounds for use as sialidase inhibitors, including alkynyl-3-fluorosialyl fluoride. The compounds, which include the compound DFSA, function by trapping a 3-fluorosialylenzyme intermediate (reporter-inhibitor-enzyme conjugate). These compounds can be conjugated with a detectable tagging moiety for isolation and identification of sialidases.
Who is the assignee on this patent?
Academia Sinica
What technology area does this patent fall under?
Primary CPC classification C12Q1/34. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Feb 26 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 12 related publications on this page (citations in our corpus or others sharing the same primary CPC).